Cinctive Capital Management LP

Position in INSM — INSMED Inc

CIK 1787258 New York, NY

Position in INSM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$11,947,261

+$8,824,114 QoQ

Shares Held

73,063

+307.1% QoQ

Ownership

0.034%

of shares outstanding

% of Portfolio

0.79%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cinctive Capital Management LP holds $185,949,026 across 51 Biotechnology names. INSM ranks #1 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc This page	73,063	$11,947,261
2	BBIO	BridgeBio Pharma, Inc.	145,728	$10,821,761
3	NTHI	Neonc Technologies Holdings, Inc.	1,425,526	$9,992,937
4	DAWN	Day One Biopharmaceuticals, Inc.	450,000	$9,648,000
5	ACLX	Arcellx, Inc.	80,000	$9,185,600
6	RVMD	Revolution Medicines, Inc.	93,857	$9,127,593
7	SRRK	Scholar Rock Holding Corp	172,535	$8,481,820
8	MDGL	Madrigal Pharmaceuticals, Inc.	15,326	$8,022,701

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,947,261	73,063	+307.1%	Shares	Sole	2026-05-15
2025-12-31	$3,123,147	17,945	-72.9%	Shares	Sole	2026-02-17
2025-09-30	$9,530,725	66,181	+101.3%	Shares	Sole	2025-11-14
2025-06-30	$3,308,439	32,874	+39.6%	Shares	Sole	2025-08-14
2025-03-31	$1,796,858	23,553	-6.7%	Shares	Sole	2025-05-15
2024-12-31	$1,743,398	25,252	-17.8%	Shares	Sole	2025-02-12
2024-09-30	$2,241,538	30,706	-78.9%	Shares	Sole	2024-11-14
2024-06-30	$9,752,319	145,557	+141.5%	Shares	Sole	2024-08-14
2024-03-31	$1,634,935	60,263	-65.6%	Shares	Sole	2024-05-15
2023-12-31	$5,423,250	175,000	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.